nodes	percent_of_prediction	percent_of_DWPC	metapath
Montelukast—CYP2A6—Valproic Acid—migraine	0.126	0.186	CbGbCtD
Montelukast—PTGS1—Valproic Acid—migraine	0.108	0.159	CbGbCtD
Montelukast—CYP2C8—Amitriptyline—migraine	0.0683	0.101	CbGbCtD
Montelukast—CYP2C8—Valproic Acid—migraine	0.0622	0.0919	CbGbCtD
Montelukast—CYP2C8—Verapamil—migraine	0.0542	0.08	CbGbCtD
Montelukast—CYP2C9—Amitriptyline—migraine	0.0476	0.0703	CbGbCtD
Montelukast—CYP2C9—Valproic Acid—migraine	0.0434	0.0641	CbGbCtD
Montelukast—CYP2C9—Verapamil—migraine	0.0378	0.0558	CbGbCtD
Montelukast—CYP3A4—Propranolol—migraine	0.032	0.0473	CbGbCtD
Montelukast—CYP3A4—Amitriptyline—migraine	0.0277	0.0409	CbGbCtD
Montelukast—CYP3A4—Valproic Acid—migraine	0.0252	0.0373	CbGbCtD
Montelukast—CYP3A4—Topiramate—migraine	0.0228	0.0336	CbGbCtD
Montelukast—CYP3A4—Verapamil—migraine	0.022	0.0324	CbGbCtD
Montelukast—CYSLTR1—Endothelins—EDNRA—migraine	0.000879	0.0381	CbGpPWpGaD
Montelukast—CYSLTR1—G alpha (q) signalling events—HTR2B—migraine	0.000625	0.0271	CbGpPWpGaD
Montelukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.000559	0.0242	CbGpPWpGaD
Montelukast—Sinusitis—Timolol—migraine	0.00054	0.00181	CcSEcCtD
Montelukast—Pneumonia—Gabapentin—migraine	0.000539	0.0018	CcSEcCtD
Montelukast—Infestation—Gabapentin—migraine	0.000536	0.00179	CcSEcCtD
Montelukast—Drowsiness—Gabapentin—migraine	0.000536	0.00179	CcSEcCtD
Montelukast—Infestation NOS—Gabapentin—migraine	0.000536	0.00179	CcSEcCtD
Montelukast—PTGS1—Prostaglandin Synthesis and Regulation—EDNRA—migraine	0.000535	0.0232	CbGpPWpGaD
Montelukast—Stevens-Johnson syndrome—Gabapentin—migraine	0.000531	0.00178	CcSEcCtD
Montelukast—Diarrhoea—Amitriptyline—migraine	0.000531	0.00178	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Verapamil—migraine	0.00053	0.00177	CcSEcCtD
Montelukast—Toxic epidermal necrolysis—Topiramate—migraine	0.000527	0.00176	CcSEcCtD
Montelukast—Aspartate aminotransferase increased—Topiramate—migraine	0.000527	0.00176	CcSEcCtD
Montelukast—Insomnia—Verapamil—migraine	0.000526	0.00176	CcSEcCtD
Montelukast—Neuropathy peripheral—Gabapentin—migraine	0.000525	0.00176	CcSEcCtD
Montelukast—Immune system disorder—Valproic Acid—migraine	0.000524	0.00175	CcSEcCtD
Montelukast—Nasopharyngitis—Topiramate—migraine	0.000523	0.00175	CcSEcCtD
Montelukast—Mediastinal disorder—Valproic Acid—migraine	0.000523	0.00175	CcSEcCtD
Montelukast—Jaundice—Gabapentin—migraine	0.000522	0.00175	CcSEcCtD
Montelukast—Paraesthesia—Verapamil—migraine	0.000522	0.00175	CcSEcCtD
Montelukast—Conjunctivitis—Gabapentin—migraine	0.000521	0.00174	CcSEcCtD
Montelukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000519	0.0225	CbGpPWpGaD
Montelukast—Rhinitis—Timolol—migraine	0.000518	0.00173	CcSEcCtD
Montelukast—Somnolence—Verapamil—migraine	0.000517	0.00173	CcSEcCtD
Montelukast—Gastrointestinal pain—Propranolol—migraine	0.000517	0.00173	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Topiramate—migraine	0.000516	0.00173	CcSEcCtD
Montelukast—Hallucination—Timolol—migraine	0.000514	0.00172	CcSEcCtD
Montelukast—Dizziness—Amitriptyline—migraine	0.000513	0.00172	CcSEcCtD
Montelukast—Dyspepsia—Verapamil—migraine	0.000512	0.00171	CcSEcCtD
Montelukast—Mental disorder—Valproic Acid—migraine	0.000508	0.0017	CcSEcCtD
Montelukast—Connective tissue disorder—Timolol—migraine	0.000508	0.0017	CcSEcCtD
Montelukast—Hepatobiliary disease—Gabapentin—migraine	0.000507	0.0017	CcSEcCtD
Montelukast—Asthma—Topiramate—migraine	0.000506	0.00169	CcSEcCtD
Montelukast—Epistaxis—Gabapentin—migraine	0.000506	0.00169	CcSEcCtD
Montelukast—Sinusitis—Gabapentin—migraine	0.000503	0.00168	CcSEcCtD
Montelukast—Urticaria—Propranolol—migraine	0.000502	0.00168	CcSEcCtD
Montelukast—Fatigue—Verapamil—migraine	0.000501	0.00168	CcSEcCtD
Montelukast—Eosinophilia—Topiramate—migraine	0.000501	0.00167	CcSEcCtD
Montelukast—Abdominal pain—Propranolol—migraine	0.0005	0.00167	CcSEcCtD
Montelukast—Body temperature increased—Propranolol—migraine	0.0005	0.00167	CcSEcCtD
Montelukast—Pain—Verapamil—migraine	0.000497	0.00166	CcSEcCtD
Montelukast—Pancreatitis—Topiramate—migraine	0.000496	0.00166	CcSEcCtD
Montelukast—Vomiting—Amitriptyline—migraine	0.000494	0.00165	CcSEcCtD
Montelukast—Rash—Amitriptyline—migraine	0.00049	0.00164	CcSEcCtD
Montelukast—Dermatitis—Amitriptyline—migraine	0.000489	0.00164	CcSEcCtD
Montelukast—Headache—Amitriptyline—migraine	0.000486	0.00163	CcSEcCtD
Montelukast—Bronchitis—Topiramate—migraine	0.000486	0.00163	CcSEcCtD
Montelukast—Muscle spasms—Valproic Acid—migraine	0.000486	0.00162	CcSEcCtD
Montelukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000483	0.0209	CbGpPWpGaD
Montelukast—Rhinitis—Gabapentin—migraine	0.000482	0.00161	CcSEcCtD
Montelukast—Hepatitis—Gabapentin—migraine	0.000481	0.00161	CcSEcCtD
Montelukast—Cardiac disorder—Timolol—migraine	0.000479	0.0016	CcSEcCtD
Montelukast—Hallucination—Gabapentin—migraine	0.000479	0.0016	CcSEcCtD
Montelukast—Hypoaesthesia—Gabapentin—migraine	0.000479	0.0016	CcSEcCtD
Montelukast—Pharyngitis—Gabapentin—migraine	0.000478	0.0016	CcSEcCtD
Montelukast—Urinary tract disorder—Gabapentin—migraine	0.000475	0.00159	CcSEcCtD
Montelukast—Tremor—Valproic Acid—migraine	0.000473	0.00158	CcSEcCtD
Montelukast—Connective tissue disorder—Gabapentin—migraine	0.000473	0.00158	CcSEcCtD
Montelukast—Urethral disorder—Gabapentin—migraine	0.000472	0.00158	CcSEcCtD
Montelukast—Upper respiratory tract infection—Topiramate—migraine	0.00047	0.00157	CcSEcCtD
Montelukast—Immune system disorder—Timolol—migraine	0.000467	0.00156	CcSEcCtD
Montelukast—CYSLTR1—GPCR ligand binding—RAMP1—migraine	0.000466	0.0202	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR ligand binding—CALCRL—migraine	0.000466	0.0202	CbGpPWpGaD
Montelukast—Hypersensitivity—Propranolol—migraine	0.000466	0.00156	CcSEcCtD
Montelukast—Mediastinal disorder—Timolol—migraine	0.000466	0.00156	CcSEcCtD
Montelukast—Agitation—Valproic Acid—migraine	0.000464	0.00155	CcSEcCtD
Montelukast—Urticaria—Verapamil—migraine	0.000462	0.00155	CcSEcCtD
Montelukast—Angioedema—Valproic Acid—migraine	0.000462	0.00154	CcSEcCtD
Montelukast—Nausea—Amitriptyline—migraine	0.000461	0.00154	CcSEcCtD
Montelukast—Erythema multiforme—Gabapentin—migraine	0.000455	0.00152	CcSEcCtD
Montelukast—Asthenia—Propranolol—migraine	0.000454	0.00152	CcSEcCtD
Montelukast—Pneumonia—Topiramate—migraine	0.000454	0.00152	CcSEcCtD
Montelukast—Mental disorder—Timolol—migraine	0.000453	0.00151	CcSEcCtD
Montelukast—Infestation—Topiramate—migraine	0.000451	0.00151	CcSEcCtD
Montelukast—Infestation NOS—Topiramate—migraine	0.000451	0.00151	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Topiramate—migraine	0.000447	0.0015	CcSEcCtD
Montelukast—Cardiac disorder—Gabapentin—migraine	0.000447	0.00149	CcSEcCtD
Montelukast—Palpitations—Valproic Acid—migraine	0.000446	0.00149	CcSEcCtD
Montelukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000445	0.0193	CbGpPWpGaD
Montelukast—CYSLTR1—Endothelins—FOS—migraine	0.000443	0.0192	CbGpPWpGaD
Montelukast—Neuropathy peripheral—Topiramate—migraine	0.000442	0.00148	CcSEcCtD
Montelukast—Cough—Valproic Acid—migraine	0.000441	0.00147	CcSEcCtD
Montelukast—Conjunctivitis—Topiramate—migraine	0.000438	0.00147	CcSEcCtD
Montelukast—Immune system disorder—Gabapentin—migraine	0.000435	0.00145	CcSEcCtD
Montelukast—Mediastinal disorder—Gabapentin—migraine	0.000434	0.00145	CcSEcCtD
Montelukast—Diarrhoea—Propranolol—migraine	0.000433	0.00145	CcSEcCtD
Montelukast—Myalgia—Valproic Acid—migraine	0.00043	0.00144	CcSEcCtD
Montelukast—Arthralgia—Valproic Acid—migraine	0.00043	0.00144	CcSEcCtD
Montelukast—Anxiety—Valproic Acid—migraine	0.000429	0.00143	CcSEcCtD
Montelukast—Hypersensitivity—Verapamil—migraine	0.000428	0.00143	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000427	0.00143	CcSEcCtD
Montelukast—Epistaxis—Topiramate—migraine	0.000425	0.00142	CcSEcCtD
Montelukast—Sinusitis—Topiramate—migraine	0.000423	0.00141	CcSEcCtD
Montelukast—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—FOS—migraine	0.000422	0.0183	CbGpPWpGaD
Montelukast—Mental disorder—Gabapentin—migraine	0.000422	0.00141	CcSEcCtD
Montelukast—Dizziness—Propranolol—migraine	0.000418	0.0014	CcSEcCtD
Montelukast—Asthenia—Verapamil—migraine	0.000417	0.0014	CcSEcCtD
Montelukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000414	0.0179	CbGpPWpGaD
Montelukast—Anaphylactic shock—Valproic Acid—migraine	0.000412	0.00138	CcSEcCtD
Montelukast—Oedema—Valproic Acid—migraine	0.000412	0.00138	CcSEcCtD
Montelukast—Pruritus—Verapamil—migraine	0.000411	0.00138	CcSEcCtD
Montelukast—Angioedema—Timolol—migraine	0.000411	0.00137	CcSEcCtD
Montelukast—Infection—Valproic Acid—migraine	0.00041	0.00137	CcSEcCtD
Montelukast—Rhinitis—Topiramate—migraine	0.000406	0.00136	CcSEcCtD
Montelukast—Hepatitis—Topiramate—migraine	0.000405	0.00135	CcSEcCtD
Montelukast—Nervous system disorder—Valproic Acid—migraine	0.000404	0.00135	CcSEcCtD
Montelukast—Thrombocytopenia—Valproic Acid—migraine	0.000404	0.00135	CcSEcCtD
Montelukast—Hallucination—Topiramate—migraine	0.000403	0.00135	CcSEcCtD
Montelukast—Hypoaesthesia—Topiramate—migraine	0.000403	0.00135	CcSEcCtD
Montelukast—Muscle spasms—Gabapentin—migraine	0.000403	0.00135	CcSEcCtD
Montelukast—Vomiting—Propranolol—migraine	0.000402	0.00134	CcSEcCtD
Montelukast—Pharyngitis—Topiramate—migraine	0.000402	0.00134	CcSEcCtD
Montelukast—Skin disorder—Valproic Acid—migraine	0.0004	0.00134	CcSEcCtD
Montelukast—Urinary tract disorder—Topiramate—migraine	0.0004	0.00134	CcSEcCtD
Montelukast—Rash—Propranolol—migraine	0.000399	0.00133	CcSEcCtD
Montelukast—Dermatitis—Propranolol—migraine	0.000398	0.00133	CcSEcCtD
Montelukast—Diarrhoea—Verapamil—migraine	0.000398	0.00133	CcSEcCtD
Montelukast—Connective tissue disorder—Topiramate—migraine	0.000398	0.00133	CcSEcCtD
Montelukast—Palpitations—Timolol—migraine	0.000397	0.00133	CcSEcCtD
Montelukast—Urethral disorder—Topiramate—migraine	0.000397	0.00133	CcSEcCtD
Montelukast—Cough—Timolol—migraine	0.000392	0.00131	CcSEcCtD
Montelukast—Tremor—Gabapentin—migraine	0.000392	0.00131	CcSEcCtD
Montelukast—CYSLTR1—G alpha (q) signalling events—TAC1—migraine	0.000386	0.0167	CbGpPWpGaD
Montelukast—CYSLTR1—G alpha (q) signalling events—NPS—migraine	0.000386	0.0167	CbGpPWpGaD
Montelukast—Agitation—Gabapentin—migraine	0.000385	0.00129	CcSEcCtD
Montelukast—Dizziness—Verapamil—migraine	0.000385	0.00129	CcSEcCtD
Montelukast—Arthralgia—Timolol—migraine	0.000383	0.00128	CcSEcCtD
Montelukast—Myalgia—Timolol—migraine	0.000383	0.00128	CcSEcCtD
Montelukast—Erythema multiforme—Topiramate—migraine	0.000383	0.00128	CcSEcCtD
Montelukast—Angioedema—Gabapentin—migraine	0.000383	0.00128	CcSEcCtD
Montelukast—Anxiety—Timolol—migraine	0.000382	0.00128	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.00038	0.00127	CcSEcCtD
Montelukast—CYSLTR1—G alpha (q) signalling events—HTR2C—migraine	0.000378	0.0164	CbGpPWpGaD
Montelukast—Musculoskeletal discomfort—Valproic Acid—migraine	0.000376	0.00126	CcSEcCtD
Montelukast—Cardiac disorder—Topiramate—migraine	0.000376	0.00126	CcSEcCtD
Montelukast—Nausea—Propranolol—migraine	0.000376	0.00126	CcSEcCtD
Montelukast—Insomnia—Valproic Acid—migraine	0.000373	0.00125	CcSEcCtD
Montelukast—Paraesthesia—Valproic Acid—migraine	0.00037	0.00124	CcSEcCtD
Montelukast—Palpitations—Gabapentin—migraine	0.00037	0.00124	CcSEcCtD
Montelukast—Vomiting—Verapamil—migraine	0.00037	0.00124	CcSEcCtD
Montelukast—CYSLTR1—G alpha (q) signalling events—EDNRA—migraine	0.000368	0.016	CbGpPWpGaD
Montelukast—Anaphylactic shock—Timolol—migraine	0.000367	0.00123	CcSEcCtD
Montelukast—Oedema—Timolol—migraine	0.000367	0.00123	CcSEcCtD
Montelukast—Rash—Verapamil—migraine	0.000367	0.00123	CcSEcCtD
Montelukast—Somnolence—Valproic Acid—migraine	0.000367	0.00123	CcSEcCtD
Montelukast—Dermatitis—Verapamil—migraine	0.000366	0.00123	CcSEcCtD
Montelukast—Immune system disorder—Topiramate—migraine	0.000366	0.00122	CcSEcCtD
Montelukast—Cough—Gabapentin—migraine	0.000365	0.00122	CcSEcCtD
Montelukast—Mediastinal disorder—Topiramate—migraine	0.000365	0.00122	CcSEcCtD
Montelukast—Infection—Timolol—migraine	0.000365	0.00122	CcSEcCtD
Montelukast—Headache—Verapamil—migraine	0.000364	0.00122	CcSEcCtD
Montelukast—Dyspepsia—Valproic Acid—migraine	0.000363	0.00121	CcSEcCtD
Montelukast—Convulsion—Gabapentin—migraine	0.000363	0.00121	CcSEcCtD
Montelukast—Nervous system disorder—Timolol—migraine	0.00036	0.0012	CcSEcCtD
Montelukast—SLCO2B1—Transmembrane transport of small molecules—TRPM8—migraine	0.000359	0.0156	CbGpPWpGaD
Montelukast—Arthralgia—Gabapentin—migraine	0.000357	0.00119	CcSEcCtD
Montelukast—Myalgia—Gabapentin—migraine	0.000357	0.00119	CcSEcCtD
Montelukast—Skin disorder—Timolol—migraine	0.000357	0.00119	CcSEcCtD
Montelukast—Gastrointestinal disorder—Valproic Acid—migraine	0.000356	0.00119	CcSEcCtD
Montelukast—Fatigue—Valproic Acid—migraine	0.000355	0.00119	CcSEcCtD
Montelukast—Anxiety—Gabapentin—migraine	0.000355	0.00119	CcSEcCtD
Montelukast—Mental disorder—Topiramate—migraine	0.000355	0.00119	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000354	0.00118	CcSEcCtD
Montelukast—Pain—Valproic Acid—migraine	0.000353	0.00118	CcSEcCtD
Montelukast—Nausea—Verapamil—migraine	0.000345	0.00116	CcSEcCtD
Montelukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000345	0.015	CbGpPWpGaD
Montelukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000345	0.015	CbGpPWpGaD
Montelukast—Anaphylactic shock—Gabapentin—migraine	0.000342	0.00114	CcSEcCtD
Montelukast—Oedema—Gabapentin—migraine	0.000342	0.00114	CcSEcCtD
Montelukast—Infection—Gabapentin—migraine	0.00034	0.00114	CcSEcCtD
Montelukast—CYSLTR1—GPCR ligand binding—HTR1D—migraine	0.000339	0.0147	CbGpPWpGaD
Montelukast—Muscle spasms—Topiramate—migraine	0.000339	0.00113	CcSEcCtD
Montelukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000338	0.0147	CbGpPWpGaD
Montelukast—Gastrointestinal pain—Valproic Acid—migraine	0.000337	0.00113	CcSEcCtD
Montelukast—Nervous system disorder—Gabapentin—migraine	0.000335	0.00112	CcSEcCtD
Montelukast—Thrombocytopenia—Gabapentin—migraine	0.000335	0.00112	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Timolol—migraine	0.000334	0.00112	CcSEcCtD
Montelukast—Skin disorder—Gabapentin—migraine	0.000332	0.00111	CcSEcCtD
Montelukast—Insomnia—Timolol—migraine	0.000332	0.00111	CcSEcCtD
Montelukast—Tremor—Topiramate—migraine	0.00033	0.0011	CcSEcCtD
Montelukast—Paraesthesia—Timolol—migraine	0.00033	0.0011	CcSEcCtD
Montelukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.000329	0.0143	CbGpPWpGaD
Montelukast—ALOX5—Selenium Micronutrient Network—MTHFR—migraine	0.000328	0.0142	CbGpPWpGaD
Montelukast—Urticaria—Valproic Acid—migraine	0.000328	0.0011	CcSEcCtD
Montelukast—Somnolence—Timolol—migraine	0.000326	0.00109	CcSEcCtD
Montelukast—Body temperature increased—Valproic Acid—migraine	0.000326	0.00109	CcSEcCtD
Montelukast—Abdominal pain—Valproic Acid—migraine	0.000326	0.00109	CcSEcCtD
Montelukast—Agitation—Topiramate—migraine	0.000324	0.00108	CcSEcCtD
Montelukast—Dyspepsia—Timolol—migraine	0.000323	0.00108	CcSEcCtD
Montelukast—Gastrointestinal disorder—Timolol—migraine	0.000317	0.00106	CcSEcCtD
Montelukast—Fatigue—Timolol—migraine	0.000316	0.00106	CcSEcCtD
Montelukast—CYSLTR1—GPCR ligand binding—HTR2B—migraine	0.000315	0.0137	CbGpPWpGaD
Montelukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000315	0.0136	CbGpPWpGaD
Montelukast—Pain—Timolol—migraine	0.000314	0.00105	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Gabapentin—migraine	0.000311	0.00104	CcSEcCtD
Montelukast—Palpitations—Topiramate—migraine	0.000311	0.00104	CcSEcCtD
Montelukast—Insomnia—Gabapentin—migraine	0.000309	0.00103	CcSEcCtD
Montelukast—Cough—Topiramate—migraine	0.000307	0.00103	CcSEcCtD
Montelukast—Paraesthesia—Gabapentin—migraine	0.000307	0.00103	CcSEcCtD
Montelukast—Convulsion—Topiramate—migraine	0.000305	0.00102	CcSEcCtD
Montelukast—Somnolence—Gabapentin—migraine	0.000304	0.00102	CcSEcCtD
Montelukast—Hypersensitivity—Valproic Acid—migraine	0.000304	0.00102	CcSEcCtD
Montelukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000303	0.0131	CbGpPWpGaD
Montelukast—Dyspepsia—Gabapentin—migraine	0.000301	0.00101	CcSEcCtD
Montelukast—Gastrointestinal pain—Timolol—migraine	0.0003	0.001	CcSEcCtD
Montelukast—Myalgia—Topiramate—migraine	0.0003	0.001	CcSEcCtD
Montelukast—Arthralgia—Topiramate—migraine	0.0003	0.001	CcSEcCtD
Montelukast—Anxiety—Topiramate—migraine	0.000299	0.001	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000298	0.000996	CcSEcCtD
Montelukast—Asthenia—Valproic Acid—migraine	0.000296	0.000989	CcSEcCtD
Montelukast—Gastrointestinal disorder—Gabapentin—migraine	0.000295	0.000987	CcSEcCtD
Montelukast—CYP2A6—Fluoropyrimidine Activity—MTHFR—migraine	0.000295	0.0128	CbGpPWpGaD
Montelukast—Fatigue—Gabapentin—migraine	0.000295	0.000986	CcSEcCtD
Montelukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000292	0.0127	CbGpPWpGaD
Montelukast—Pain—Gabapentin—migraine	0.000292	0.000978	CcSEcCtD
Montelukast—Pruritus—Valproic Acid—migraine	0.000292	0.000976	CcSEcCtD
Montelukast—Urticaria—Timolol—migraine	0.000292	0.000975	CcSEcCtD
Montelukast—Abdominal pain—Timolol—migraine	0.00029	0.00097	CcSEcCtD
Montelukast—Body temperature increased—Timolol—migraine	0.00029	0.00097	CcSEcCtD
Montelukast—Oedema—Topiramate—migraine	0.000288	0.000962	CcSEcCtD
Montelukast—Infection—Topiramate—migraine	0.000286	0.000955	CcSEcCtD
Montelukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000285	0.0123	CbGpPWpGaD
Montelukast—Diarrhoea—Valproic Acid—migraine	0.000282	0.000944	CcSEcCtD
Montelukast—Nervous system disorder—Topiramate—migraine	0.000282	0.000943	CcSEcCtD
Montelukast—Thrombocytopenia—Topiramate—migraine	0.000282	0.000942	CcSEcCtD
Montelukast—Gastrointestinal pain—Gabapentin—migraine	0.00028	0.000935	CcSEcCtD
Montelukast—Skin disorder—Topiramate—migraine	0.000279	0.000934	CcSEcCtD
Montelukast—Dizziness—Valproic Acid—migraine	0.000273	0.000912	CcSEcCtD
Montelukast—SLCO2B1—Transmembrane transport of small molecules—ATP1A3—migraine	0.000272	0.0118	CbGpPWpGaD
Montelukast—SLCO2B1—Transmembrane transport of small molecules—ATP1A2—migraine	0.000272	0.0118	CbGpPWpGaD
Montelukast—Urticaria—Gabapentin—migraine	0.000272	0.000908	CcSEcCtD
Montelukast—Hypersensitivity—Timolol—migraine	0.00027	0.000904	CcSEcCtD
Montelukast—Body temperature increased—Gabapentin—migraine	0.00027	0.000904	CcSEcCtD
Montelukast—Abdominal pain—Gabapentin—migraine	0.00027	0.000904	CcSEcCtD
Montelukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.00027	0.0117	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—CALCRL—migraine	0.000264	0.0114	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—RAMP1—migraine	0.000264	0.0114	CbGpPWpGaD
Montelukast—Asthenia—Timolol—migraine	0.000263	0.000881	CcSEcCtD
Montelukast—Vomiting—Valproic Acid—migraine	0.000262	0.000877	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Topiramate—migraine	0.000262	0.000876	CcSEcCtD
Montelukast—Insomnia—Topiramate—migraine	0.00026	0.00087	CcSEcCtD
Montelukast—Rash—Valproic Acid—migraine	0.00026	0.000869	CcSEcCtD
Montelukast—Dermatitis—Valproic Acid—migraine	0.00026	0.000869	CcSEcCtD
Montelukast—Pruritus—Timolol—migraine	0.00026	0.000869	CcSEcCtD
Montelukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000259	0.0112	CbGpPWpGaD
Montelukast—Headache—Valproic Acid—migraine	0.000258	0.000864	CcSEcCtD
Montelukast—Paraesthesia—Topiramate—migraine	0.000258	0.000864	CcSEcCtD
Montelukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000256	0.0111	CbGpPWpGaD
Montelukast—Somnolence—Topiramate—migraine	0.000256	0.000855	CcSEcCtD
Montelukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000256	0.0111	CbGpPWpGaD
Montelukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000256	0.0111	CbGpPWpGaD
Montelukast—Dyspepsia—Topiramate—migraine	0.000253	0.000847	CcSEcCtD
Montelukast—Hypersensitivity—Gabapentin—migraine	0.000252	0.000842	CcSEcCtD
Montelukast—Diarrhoea—Timolol—migraine	0.000251	0.00084	CcSEcCtD
Montelukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000251	0.0109	CbGpPWpGaD
Montelukast—Gastrointestinal disorder—Topiramate—migraine	0.000248	0.00083	CcSEcCtD
Montelukast—Fatigue—Topiramate—migraine	0.000248	0.000829	CcSEcCtD
Montelukast—Pain—Topiramate—migraine	0.000246	0.000822	CcSEcCtD
Montelukast—Asthenia—Gabapentin—migraine	0.000245	0.00082	CcSEcCtD
Montelukast—Nausea—Valproic Acid—migraine	0.000245	0.000819	CcSEcCtD
Montelukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000244	0.0106	CbGpPWpGaD
Montelukast—Dizziness—Timolol—migraine	0.000243	0.000812	CcSEcCtD
Montelukast—Pruritus—Gabapentin—migraine	0.000242	0.000809	CcSEcCtD
Montelukast—CYSLTR1—Signaling by GPCR—CALCRL—migraine	0.000239	0.0104	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—RAMP1—migraine	0.000239	0.0104	CbGpPWpGaD
Montelukast—Gastrointestinal pain—Topiramate—migraine	0.000235	0.000786	CcSEcCtD
Montelukast—Diarrhoea—Gabapentin—migraine	0.000234	0.000782	CcSEcCtD
Montelukast—Vomiting—Timolol—migraine	0.000233	0.000781	CcSEcCtD
Montelukast—CYSLTR1—G alpha (q) signalling events—HTR2A—migraine	0.000232	0.0101	CbGpPWpGaD
Montelukast—SLCO2B1—Transmembrane transport of small molecules—HTR3A—migraine	0.000232	0.01	CbGpPWpGaD
Montelukast—Rash—Timolol—migraine	0.000231	0.000774	CcSEcCtD
Montelukast—Dermatitis—Timolol—migraine	0.000231	0.000773	CcSEcCtD
Montelukast—Headache—Timolol—migraine	0.00023	0.000769	CcSEcCtD
Montelukast—Urticaria—Topiramate—migraine	0.000228	0.000764	CcSEcCtD
Montelukast—Body temperature increased—Topiramate—migraine	0.000227	0.00076	CcSEcCtD
Montelukast—Abdominal pain—Topiramate—migraine	0.000227	0.00076	CcSEcCtD
Montelukast—Dizziness—Gabapentin—migraine	0.000226	0.000756	CcSEcCtD
Montelukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000219	0.00951	CbGpPWpGaD
Montelukast—Nausea—Timolol—migraine	0.000218	0.000729	CcSEcCtD
Montelukast—Vomiting—Gabapentin—migraine	0.000217	0.000727	CcSEcCtD
Montelukast—Rash—Gabapentin—migraine	0.000216	0.000721	CcSEcCtD
Montelukast—Dermatitis—Gabapentin—migraine	0.000215	0.00072	CcSEcCtD
Montelukast—Headache—Gabapentin—migraine	0.000214	0.000716	CcSEcCtD
Montelukast—Hypersensitivity—Topiramate—migraine	0.000212	0.000709	CcSEcCtD
Montelukast—PTGS1—Overview of nanoparticle effects—TNF—migraine	0.000209	0.00906	CbGpPWpGaD
Montelukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000208	0.009	CbGpPWpGaD
Montelukast—Asthenia—Topiramate—migraine	0.000206	0.00069	CcSEcCtD
Montelukast—CYSLTR1—GPCR ligand binding—HTR1B—migraine	0.000205	0.0089	CbGpPWpGaD
Montelukast—Pruritus—Topiramate—migraine	0.000203	0.00068	CcSEcCtD
Montelukast—Nausea—Gabapentin—migraine	0.000203	0.000679	CcSEcCtD
Montelukast—CYSLTR1—GPCR ligand binding—HTR1A—migraine	0.000198	0.00856	CbGpPWpGaD
Montelukast—Diarrhoea—Topiramate—migraine	0.000197	0.000658	CcSEcCtD
Montelukast—CYSLTR1—GPCR ligand binding—TAC1—migraine	0.000195	0.00843	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR ligand binding—NPS—migraine	0.000195	0.00843	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—HTR1D—migraine	0.000191	0.0083	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR ligand binding—HTR2C—migraine	0.000191	0.00827	CbGpPWpGaD
Montelukast—Dizziness—Topiramate—migraine	0.00019	0.000636	CcSEcCtD
Montelukast—CYSLTR1—GPCR ligand binding—EDNRA—migraine	0.000186	0.00805	CbGpPWpGaD
Montelukast—Vomiting—Topiramate—migraine	0.000183	0.000612	CcSEcCtD
Montelukast—Rash—Topiramate—migraine	0.000181	0.000606	CcSEcCtD
Montelukast—Dermatitis—Topiramate—migraine	0.000181	0.000606	CcSEcCtD
Montelukast—Headache—Topiramate—migraine	0.00018	0.000603	CcSEcCtD
Montelukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000179	0.00778	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR ligand binding—CALCA—migraine	0.000179	0.00774	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—HTR2B—migraine	0.000178	0.00771	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—HTR1D—migraine	0.000174	0.00754	CbGpPWpGaD
Montelukast—Nausea—Topiramate—migraine	0.000171	0.000571	CcSEcCtD
Montelukast—CYSLTR1—GPCR ligand binding—HTR7—migraine	0.000167	0.00724	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—HTR2B—migraine	0.000162	0.00701	CbGpPWpGaD
Montelukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000154	0.00666	CbGpPWpGaD
Montelukast—CYP2A6—NRF2 pathway—SLC6A4—migraine	0.000147	0.00635	CbGpPWpGaD
Montelukast—PTGS1—Selenium Micronutrient Network—MTHFR—migraine	0.000142	0.00617	CbGpPWpGaD
Montelukast—ALOX5—Selenium Micronutrient Network—TNF—migraine	0.000141	0.00613	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—RAMP1—migraine	0.000141	0.00613	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CALCRL—migraine	0.000141	0.00613	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR ligand binding—HTR2A—migraine	0.000117	0.00507	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—HTR1B—migraine	0.000116	0.00503	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—HTR1A—migraine	0.000112	0.00484	CbGpPWpGaD
Montelukast—CYP2A6—NRF2 pathway—TGFBR2—migraine	0.000111	0.00479	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—NPS—migraine	0.00011	0.00477	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—TAC1—migraine	0.00011	0.00477	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—HTR2C—migraine	0.000108	0.00467	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—HTR1B—migraine	0.000105	0.00457	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—EDNRA—migraine	0.000105	0.00455	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—HTR1D—migraine	0.000103	0.00445	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—HTR1A—migraine	0.000101	0.00439	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—CALCA—migraine	0.000101	0.00438	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—TAC1—migraine	9.99e-05	0.00433	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—NPS—migraine	9.99e-05	0.00433	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—CACNA1A—migraine	9.93e-05	0.0043	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—HTR2C—migraine	9.79e-05	0.00424	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—HTR2B—migraine	9.55e-05	0.00414	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—EDNRA—migraine	9.53e-05	0.00413	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—HTR7—migraine	9.45e-05	0.00409	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—CALCA—migraine	9.17e-05	0.00397	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—HTR7—migraine	8.58e-05	0.00372	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—LRP1—migraine	8.41e-05	0.00364	CbGpPWpGaD
Montelukast—CYSLTR1—trigeminal ganglion—migraine	8.34e-05	0.134	CbGeAlD
Montelukast—CYSLTR1—GPCR downstream signaling—HTR2A—migraine	6.62e-05	0.00287	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—NOTCH4—migraine	6.45e-05	0.0028	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—HTR1B—migraine	6.22e-05	0.0027	CbGpPWpGaD
Montelukast—PTGS1—Selenium Micronutrient Network—TNF—migraine	6.13e-05	0.00266	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—HTR2A—migraine	6.01e-05	0.0026	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—HTR1A—migraine	5.99e-05	0.0026	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TAC1—migraine	5.9e-05	0.00256	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PGR—migraine	5.9e-05	0.00256	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—NPS—migraine	5.9e-05	0.00256	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—HTR2C—migraine	5.78e-05	0.00251	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—EDNRA—migraine	5.63e-05	0.00244	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—NOTCH3—migraine	5.48e-05	0.00238	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CALCA—migraine	5.42e-05	0.00235	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—HTR7—migraine	5.07e-05	0.0022	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TGFBR2—migraine	4.36e-05	0.00189	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CACNA1A—migraine	4.31e-05	0.00187	CbGpPWpGaD
Montelukast—CYSLTR1—head—migraine	4.08e-05	0.0657	CbGeAlD
Montelukast—CYP2A6—Metabolism—CACNA1A—migraine	4.07e-05	0.00176	CbGpPWpGaD
Montelukast—CYSLTR1—nervous system—migraine	3.87e-05	0.0623	CbGeAlD
Montelukast—CYSLTR1—central nervous system—migraine	3.72e-05	0.06	CbGeAlD
Montelukast—ALOX5—cardiovascular system—migraine	3.65e-05	0.0588	CbGeAlD
Montelukast—CYSLTR1—Signaling Pathways—HTR2A—migraine	3.55e-05	0.00154	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—MTHFR—migraine	3.28e-05	0.00142	CbGpPWpGaD
Montelukast—PTGS1—blood vessel—migraine	3.28e-05	0.0529	CbGeAlD
Montelukast—CYSLTR1—Signaling Pathways—ESR1—migraine	3.15e-05	0.00137	CbGpPWpGaD
Montelukast—CYSLTR1—brain—migraine	2.96e-05	0.0476	CbGeAlD
Montelukast—CYP2C8—Metabolism—CACNA1A—migraine	2.78e-05	0.00121	CbGpPWpGaD
Montelukast—ALOX5—head—migraine	2.47e-05	0.0398	CbGeAlD
Montelukast—ALOX5—nervous system—migraine	2.34e-05	0.0377	CbGeAlD
Montelukast—CYP2C9—Metabolism—CACNA1A—migraine	2.26e-05	0.000981	CbGpPWpGaD
Montelukast—ALOX5—central nervous system—migraine	2.26e-05	0.0363	CbGeAlD
Montelukast—ALOX5—cerebellum—migraine	2.2e-05	0.0355	CbGeAlD
Montelukast—CYP2A6—cerebellum—migraine	1.94e-05	0.0313	CbGeAlD
Montelukast—SLCO2B1—head—migraine	1.9e-05	0.0306	CbGeAlD
Montelukast—SLCO2B1—nervous system—migraine	1.8e-05	0.0291	CbGeAlD
Montelukast—ALOX5—brain—migraine	1.79e-05	0.0288	CbGeAlD
Montelukast—SLCO2B1—central nervous system—migraine	1.74e-05	0.028	CbGeAlD
Montelukast—SLCO2B1—cerebellum—migraine	1.7e-05	0.0273	CbGeAlD
Montelukast—CYP2C9—cardiovascular system—migraine	1.6e-05	0.0258	CbGeAlD
Montelukast—CYP2A6—brain—migraine	1.58e-05	0.0254	CbGeAlD
Montelukast—CYP3A4—Metabolism—CACNA1A—migraine	1.49e-05	0.000647	CbGpPWpGaD
Montelukast—PTGS1—cardiovascular system—migraine	1.46e-05	0.0236	CbGeAlD
Montelukast—PTGS1—Metabolism—MTHFR—migraine	1.42e-05	0.000617	CbGpPWpGaD
Montelukast—SLCO2B1—brain—migraine	1.38e-05	0.0222	CbGeAlD
Montelukast—CYP2A6—Metabolism—MTHFR—migraine	1.35e-05	0.000584	CbGpPWpGaD
Montelukast—PTGS1—head—migraine	9.92e-06	0.016	CbGeAlD
Montelukast—PTGS1—nervous system—migraine	9.4e-06	0.0151	CbGeAlD
Montelukast—CYP2C8—Metabolism—MTHFR—migraine	9.2e-06	0.000399	CbGpPWpGaD
Montelukast—PTGS1—central nervous system—migraine	9.05e-06	0.0146	CbGeAlD
Montelukast—CYP2C8—brain—migraine	8.86e-06	0.0143	CbGeAlD
Montelukast—CYP3A4—nervous system—migraine	7.85e-06	0.0127	CbGeAlD
Montelukast—CYP3A4—central nervous system—migraine	7.56e-06	0.0122	CbGeAlD
Montelukast—CYP2C9—Metabolism—MTHFR—migraine	7.49e-06	0.000325	CbGpPWpGaD
Montelukast—PTGS1—brain—migraine	7.19e-06	0.0116	CbGeAlD
Montelukast—CYP3A4—Metabolism—MTHFR—migraine	4.94e-06	0.000214	CbGpPWpGaD
